Sharehope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 10, 2021
Share
ShareHope Medicine Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 942.413 million compared to TWD 956.071 million a year ago. Operating income was TWD 50.471 million compared to TWD 140.913 million a year ago. Net income was TWD 38.728 million compared to TWD 75.847 million a year ago. Basic earnings per share was TWD 0.36 compared to TWD 0.71 a year ago. Diluted earnings per share was TWD 0.35 compared to TWD 0.68 a year ago. For the half year, sales was TWD 1,844.230 million compared to TWD 1,798.519 million a year ago. Operating income was TWD 87.037 million compared to TWD 166.949 million a year ago. Net income was TWD 91.933 million compared to TWD 37.230 million a year ago. Basic earnings per share was TWD 0.84 compared to TWD 0.35 a year ago. Diluted earnings per share was TWD 0.82 compared to TWD 0.34 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
